The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Khunti, K.; Caputo, S.; Damci, T.; Dzida, G.; Ji, Q.; Kaiser, M.; Karnieli, E.; Liebl, A.; Ligthelm, R.; Nazeri, A.; Orozco-Beltran, D.; Pan, C.; Ross, S.; Svendsen, A.; Vora, J.; Yale, J.; Meneghini, L.

doi:10.1111/j.1463-1326.2012.01665.x

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Khunti K., Caputo S., Damci T., Dzida G. J., Ji Q., Kaiser M., ...More

DIABETES OBESITY & METABOLISM, vol.14, no.12, pp.1129-1136, 2012 (SCI-Expanded)

Publication Type: Article / Article
Volume: 14 Issue: 12
Publication Date: 2012
Doi Number: 10.1111/j.1463-1326.2012.01665.x
Journal Name: DIABETES OBESITY & METABOLISM
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1129-1136
Istanbul University Affiliated: Yes

Abstract

Aims: Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs).